These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23894157)

  • 1. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
    Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
    Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
    Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications.
    Yamamoto M; Yamaguchi T; Yamauchi M; Kaji H; Sugimoto T
    J Bone Miner Res; 2009 Apr; 24(4):702-9. PubMed ID: 19049338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance between Prevalent Vertebral Fracture and Vertebral Strength Estimated by the Finite Element Method Based on Quantitative Computed Tomography in Patients with Type 2 Diabetes Mellitus.
    Kiyohara N; Yamamoto M; Sugimoto T
    PLoS One; 2015; 10(12):e0144496. PubMed ID: 26642210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Yamauchi M; Yano S; Sugimoto T
    J Clin Endocrinol Metab; 2008 Mar; 93(3):1013-9. PubMed ID: 18160470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
    Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
    Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Nawata K; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1277-84. PubMed ID: 22337915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between sex steroids, bone turnover and vertebral fracture prevalence in asymptomatic men.
    El Maghraoui A; Ouzzif Z; Mounach A; Ben-Ghabrit A; Achemlal L; Bezza A; Ghozlani I
    Bone; 2011 Oct; 49(4):853-7. PubMed ID: 21723429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes.
    Yamaguchi T; Kanazawa I; Yamamoto M; Kurioka S; Yamauchi M; Yano S; Sugimoto T
    Bone; 2009 Aug; 45(2):174-9. PubMed ID: 19446053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalent vertebral fracture is dominantly associated with spinal microstructural deterioration rather than bone mineral density in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    PLoS One; 2019; 14(9):e0222571. PubMed ID: 31525243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Atteritano M; Di Mauro E; Canale V; Bruzzese AM; Ricciardi CA; Cernaro V; Lacquaniti A; Buemi M; Santoro D
    Osteoporos Int; 2017 Feb; 28(2):577-584. PubMed ID: 27682249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
    García-Martín A; Rozas-Moreno P; Reyes-García R; Morales-Santana S; García-Fontana B; García-Salcedo JA; Muñoz-Torres M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):234-41. PubMed ID: 22031520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
    Kanazawa I; Notsu M; Miyake H; Tanaka K; Sugimoto T
    Osteoporos Int; 2018 Nov; 29(11):2527-2535. PubMed ID: 30030585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus.
    Tanaka KI; Kanazawa I; Kaji H; Sugimoto T
    Bone; 2017 Feb; 95():5-10. PubMed ID: 27836731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
    van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
    Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study.
    Jiajue R; Qi X; Jiang Y; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
    Calcif Tissue Int; 2019 Nov; 105(5):466-475. PubMed ID: 31511960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients.
    Wang N; Xue P; Wu X; Ma J; Wang Y; Li Y
    Endocr Res; 2018 Feb; 43(1):29-38. PubMed ID: 28972408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.
    Rossini M; Viapiana O; Idolazzi L; Ghellere F; Fracassi E; Troplini S; Povino MR; Kunnathully V; Adami S; Gatti D
    Calcif Tissue Int; 2016 May; 98(5):438-45. PubMed ID: 26645432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures.
    Heilmeier U; Carpenter DR; Patsch JM; Harnish R; Joseph GB; Burghardt AJ; Baum T; Schwartz AV; Lang TF; Link TM
    Osteoporos Int; 2015 Apr; 26(4):1283-93. PubMed ID: 25582311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.